T1	Participants 145 178	patients with chronic hepatitis B
T2	Participants 320 370	Caucasian patients with chronic active hepatitis B
T3	Participants 382 421	Asian patients with chronic hepatitis B
T4	Participants 623 674	10 Chinese patients with histologically proven CAHB
T5	Participants 679 712	seven healthy Chinese individuals
T6	Participants 714 742	Four of the 10 CAHB patients
T7	Participants 1103 1136	seven Chinese control individuals
T8	Participants 1262 1278	healthy controls
T9	Participants 1388 1424	10 patients with chronic hepatitis B
T10	Participants 1453 1461	controls
T11	Participants 1636 1656	all treated patients
T12	Participants 2078 2127	patients with HBV DNA levels below 10 000 pg ml-1
T13	Participants 2174 2195	Chinese CAHB patients
T14	Participants 2224 2253	Caucasian patients with CAHB,
